Topics

Companies Related to "mechanism safely prevent reverse obesity inhibiting aryl hydrocarbon" [Most Relevant Company Matches] RSS

17:01 EST 19th February 2020 | BioPortfolio

Here are the most relevant search results for "mechanism safely prevent reverse obesity inhibiting aryl hydrocarbon" found in our extensive corporate database of over 50,000 company records.

Showing "mechanism safely prevent reverse obesity inhibiting aryl hydrocarbon" Companies 1–25 of 853

Relevant

Strategies to Overcome and Prevent (STOP) Obesity Alliance

The Strategies to Overcome and Prevent (STOP) Obesity Alliance is a collaboration of consumer, provider, government, labor, business, health insurers and quality-of-care organizations united to drive innovative and practical strategies that combat obesity.


The Obesity Society

The Obesity Society (www.obesity.org) is the leading scientific organization in North America dedicated to the study of obesity. The Obesity Society is committed to encouraging research on the causes and treatment of obesity and keeping the medical community and public informed of new advances. The Obesity Society's vision is to be the leader in understanding, preventing and treating obesity and i...

BONIVA, PPI

BONIVA is a prescription medicine used to treat or prevent osteoporosis in women after menopause. BONIVA may reverse bone loss by stopping more loss of bone and increasing bone mass in most women who take it, even though they won't be able to see or feel a difference. BONIVA may help lower the chances of breaking bones (fractures). For BONIVA to treat or prevent osteoporosis, you have to take it a...


Elixir Pharmaceuticals, Inc

We are a biopharmaceutical company utilizing aging research to develop pharmaceuticals that treat and/or prevent metabolic diseases such as obesity and diabetes. Our technology is based on the recent discovery that aging is genetically controlled and is intimately related to the diseases of obesity and diabetes. We have identified many of the genes that regulate aging and the pathways and proteins...

Aryl S.A

ARYLS.A.started its business as a pharmachemical company in 1998.The manufacturing site and the administration offices are located in Bureros Aires,Aregentina.The Company employs more than 100 people

American Board of Obesity Medicine

The American Board of Obesity Medicine (ABOM) serves the public and the field of obesity medicine through the examination and certification of candidate physicians who seek recognition of their accomplishments and knowledge in obesity medicine. Physicians who complete the ABOM certification process are designated Diplomates of the American Board of Obesity...

Affinium Pharmaceuticals

Affinium Pharmaceuticals is a specialty pharmaceutical company focused on the discovery, development and commercialization of novel anti-infective medicines. AFN-1252 utilizes a unique mechanism of action by directly inhibiting the function of the bacterial fatty acid synthesis (FAS) II pathway. Affinium’s FASII antibacterial programs constitute a new antibiotic franchise with the potential for...

Retractable Technologies

Retractable Technologies Inc. designs, develops, manufactures and markets safety needle devices for the healthcare industry. The Company's VanishPoint products utilize a patented friction ring mechanism. VanishPoint products are designed specifically to prevent needlestick injuries and to prevent reuse. The VanishPoint blood collection tube holder utilizes the same mechanism to retract the needle ...

Those Picked Last

Those Picked Last Foundation was created to educate and bring together parents, children, clinicians (psychologists, nutritionists, nurses), educators, politicians, and businesses in open forums to discuss the challenges of adolescent and childhood obesity. Those Picked Last believes that the Clinicians do not care about the politics of Obesity, the Politicians do not understand the science of Obe...

Beko

Beko will not only inspire and raise awareness about the global challenge of obesity in childhood, but has a goal to raise €1,000,000 for UNICEF by encouraging people all over the world to share their healthy eating habits on social media. For each #EatLikeAPro post that appears on Instagram or Twitter, Beko will donate €1 for UNICEF. The donatio...

Virta Health

Virta is online specialty medical clinic that reverses type 2 diabetes safely and sustainably, without the risks, costs, or side effects of medications or surgery. Drawing on decades of research, including that of our founders and advisors, Virta is driving two major innovations. First, we take a highly individualized approach to metabolic health, focused ...

Truth on Health

Paul Pierce created the Truth on Health as the main focus to his Truth Fund with the goal of building a sustainable, replicable model to prevent childhood obesity in America by providing the incentives and resources for young people lead healthier lifestyles. He launched his commitment to fight childhood obesity at the Clinton Global Initiative in Septembe...

Reverse Therapy UK Limited

John Eaton is the Founder of Reverse Therapy and has been innovating in the field of therapy since 1988. Since 1996 he has been steadily developing the ideas, techniques and principles that, collectively, he named 'Reverse Therapy' in 2002.He has brought together a unique blend of insights drawn from Bodymind healing techniques, Symptom-focused therapy and Psychobiology that forms a powerful appli...

Zucara Therapeutics

Zucara Therapeutics, a spin-off company by The Centre for Drug Research and Development (CDRD) and MaRS Innovation (MI), is developing the first drug therapy to prevent hypoglycemia in people with diabetes. The Company’s first-in-class therapeutic is aimed at inhibiting a hormone in the pancreas called somatostatin, which does not function properly in ...

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company that is creating a new class of disease-modifying therapeutics for patients with axonal degeneration, a central driver of neurological disease-causing disability and disease progression. By inhibiting the SARM1 protein, identified by the company’s scientific founders as the central driver of axonal degeneration, these therapeutics may prevent th...

ROWHEELS

Founded in 2011, ROWHEELS has developed a proprietary reverse propulsion wheel technology that can prevent wheelchair users from suffering from repetitive stress injuries of the shoulder. ROWHEELS’ patented wheel technology has been tested and endorsed in real-world situations and the results of clinical studies confirm that the system improves quality of ...

Peptimmune,Inc

Peptimmune's metabolic disease expertise is based upon polymer chemistry technologyand related ntellectual property assets. Peptimmune is using non-absorbable hydrogelpolymers as fat binding agents to improve the tolerability of lipase inhibitors for thetreatment of obesity. The polymer technology utilizes a proprietary polymer thateliminates fat coalescence. A drug candidate has been identified w...

AsclepiX Therapeutics, Inc.

AsclepiX Therapeutics is transforming the treatment of ocular diseases and cancer with a singular focus on a novel peptide platform with the power to inhibit and potentially even reverse disease progression. The mechanism of action of AXT107 targets multiple pathways, including vascular endothelial growth factor A (VEGF-A) and Tie2, two factors that promot...

WAT-AAH!

After learning that for the very first time in American history, a kid's life span is expected to be shorter than his or her parents by 5 years mainly due to the prevalence of childhood obesity, Rose Cameron (a former advertising and marketing executive) was determined to launch WAT-AAH! She was concerned by the fact that in 2007 of the 36 new drinks targeted to kids, all contained sugar, additive...

Tranzyme Pharma Inc.

Tranzyme Pharma is a clinical-stage company with a focus on novel products for the treatment of gastrointestinal and metabolic diseases. Tranzyme is developing first-in-class "mechanism-based" therapeutics for Post-operative ileus, gastroparesis, Obesity, and functional GI disorders. The Company recently completed a phase I trial of its lead product, TZP-101, and anticipates on having aq second ca...

PolyMedix Inc.

PolyMedix is a publicly traded emerging biotechnology company focused the development of novel drugs and biomaterials for the treatment of infectious diseases and acute cardiovascular disorders. PolyMedix’s compounds are based on biomimetics: non-peptide small molecule drug candidates that mimic the activity of proteins. The Company’s antibioti...

ConsortiaTX, Inc.

ConsortiaTX, Inc. is a biotherapeutic company developing therapies based on microbes and microbial products to prevent and treat human diseases. The company was formed in June of 2017 based on the research of Lynn Bry, M.D., Ph.D., Talal Chatila, M.D., and Georg Gerber M.D., Ph.D. The company’s initial therapeutic candidate, CTX-944, tar...

PolyMedix, Inc.

PolyMedix is a publicly traded biotechnology company focused on the development of novel drugs and biomaterials for the treatment of serious acute cardiovascular disorders and infectious diseases. PolyMedix uses a rational drug design approach to create non-peptide small molecule drug candidates and polymers that mimic the activity of proteins. PMX-60056, ...

Sierra Sciences, Inc

Sierra Sciences, Inc. (SSI) is a biotech research company located in Reno, Nevada. Our mission is to discover a medicine to prevent and/or reverse cellular senescence (the phenomenon where cells lose the ability to divide).We believe that cellular senescence is an underlying cause of many conditions in cells which are related to the diseases of human aging, including aging itself. SSI was founded ...

Medisafe 1 Technologies Corp.

Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.


More From BioPortfolio on "mechanism safely prevent reverse obesity inhibiting aryl hydrocarbon"

Quick Search

Corporate Database Quicklinks